Uracil / zhubný nádor

Method for treating tumors by the administration of tegafur, uracil, folinic acid, and cyclophosphamide

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

FIELD OF THE INVENTION The present invention is directed to the administration to a warm blooded animal including humans of the combination of tegafur, uracil, and folinic acid and its administration with cyclophosphamide for the treatment of tumors. BACKGROUND OF THE INVENTION 5--Fluorouracil

Composition containing 1-(n-hexylcarbamoyl)-5-fluorouracil and uracil

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

This invention relates to anti-cancer compositions, for delivering 5-fluorouracil to cancer tissues, of a cancer sensitive to 5-fluorouracil, in warm blooded animals. In recent years, various excellent anti-cancer compositions have been introduced into use for the chemotherapy of malignant cancers

Uracil reductase inactivators

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

The present invention relates to certain enzyme inactivators which are useful in medicine, particularly cancer chemotherapy, especially in combination with antimetabolite antineoplastic agents such as 5-fluorouracil (5-FU). 5-Fluorouracil has been used in cancer chemotherapy since 1957. sensitive

Uracil reductase inactivators

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

The present invention relates to certain enzyme inactivators which are useful in medicine, particularly cancer chemotherapy, especially in combination with antimetabolite antineoplastic agents such as 5-fluorouracil (5-FU). 5-Fluorouracil has been used in cancer chemotherapy since 1957. sensitive

Uracil reductase inactivatores

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

The present invention relates to certain enzyme inactivators which are useful in medicine, particularly cancer chemotherapy, especially in combination with antimetabolite antineoplastic agents such as 5-fluorouracil (5-FU). 5-Fluorouracil has been used in cancer chemotherapy since 1957. Sensitive

Cancerous metastasis inhibitors containing uracil derivatives

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

TECHNICAL FIELD This invention relates to a cancerous metastasis inhibitor which contains a uracil derivative having thymidine phosphorylase inhibiting activity. BACKGROUND ART Cancer treatments have achieved an innovative level of progress in recent years and, especially, an improvement in the

Treatment of urogenital cancer with boron neutron capture therapy

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

BACKGROUND OF THE INVENTION A. DNCT and its Prior Uses The goal of cancer therapy is to achieve a degree of selectivity that spares normal cells and destroys all malignant ones, since even a small number of remaining malignant cells can lead to recurrence, metastasis, and death. A two-component or

Treatment of urogenital cancer with boron neutron capture therapy

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

The goal of cancer therapy is to achieve a degree of selectivity that spares normal cells and destroys all malignant ones, since even a small number of remaining malignant cells can lead to recurrence, metastasis, and death. A two-component or binary system comprised of constituents that alone are

Pharmaceutical preparations and methods for inhibiting tumors

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

FIELD OF THE INVENTION The present invention relates to pharmaceutical preparations (i.e., composition) for use as tumor suppressive agents for tumors arising from cancers such as prostatic adenocarcinoma, stomach cancer, breast cancer, endometrial and ovarian cancers, and benign prostate

Pharmaceutical preparations and methods for inhibiting tumors

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

FIELD OF THE INVENTION The present invention relates to pharmaceutical preparations (i.e., composition) for use as tumor suppressive agents for tumors arising from cancers such as prostatic adenocarcinoma, stomach cancer, breast cancer, endometrial and ovarian cancers, and benign prostate

Pharmaceutical preparations and methods for inhibiting tumors

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

FIELD OF THE INVENTION The present invention relates to pharmaceutical preparations (i.e., composition) for use as tumor suppressive agents for tumors arising from cancers such as prostatic adenocarcinoma, stomach cancer, breast cancer, endometrial and ovarian cancers, and benign prostate

Uracil derivatives, and antitumor effect potentiator and antitumor agent containing the same

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

TECHNICAL FIELD This invention relates to novel uracil derivatives having excellent inhibitory effects on human-derived thymidine phosphorylase, and also to antitumor effect potentiators and antitumor agents containing same. BACKGROUND ART Unnatural pyrimidine nucleosides showing antitumor

Uracil derivatives, and antitumor effect potentiator and antitumor agent containing the same

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

This is a 371 application of PCT/JP 96/00828 filed on Mar. 28, 1996. TECHNICAL FIELD This invention relates to novel uracil derivatives having excellent inhibitory effects on human-derived thymidine phosphorylase, and also to antitumor effect potentiators and antitumor agents containing

Uracil derivatives and antitumor effect potentiator and antitumor agent containing the same

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

TECHNICAL FIELD This invention relates to novel uracil derivatives having excellent inhibitory effects on human-derived thymidine phosphorylase, and also to antitumor effect potentiators and antitumor agents containing same. BACKGROUND ART Unnatural pyrimidine nucleosides showing antitumor

Dose critical in-vivo detection of anti-cancer drug levels in blood

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

FIELD OF THE INVENTION The present invention relates generally to the in vivo detection and measurement of the dose critical levels of certain anti-cancer drugs in blood, serum and other biological fluids, more specifically to the detection of such drugs using a probe DNA and still more specifically

uracil/zhubný nádor

Method for treating tumors by the administration of tegafur, uracil, folinic acid, and cyclophosphamide

Composition containing 1-(n-hexylcarbamoyl)-5-fluorouracil and uracil

Uracil reductase inactivators

Uracil reductase inactivators

Uracil reductase inactivatores

Cancerous metastasis inhibitors containing uracil derivatives

Treatment of urogenital cancer with boron neutron capture therapy

Treatment of urogenital cancer with boron neutron capture therapy

Pharmaceutical preparations and methods for inhibiting tumors

Pharmaceutical preparations and methods for inhibiting tumors

Pharmaceutical preparations and methods for inhibiting tumors

Uracil derivatives, and antitumor effect potentiator and antitumor agent containing the same

Uracil derivatives, and antitumor effect potentiator and antitumor agent containing the same

Uracil derivatives and antitumor effect potentiator and antitumor agent containing the same

Dose critical in-vivo detection of anti-cancer drug levels in blood

Najkompletnejšia databáza liečivých bylín podporovaná vedou